Results 111 to 120 of about 60,399 (202)

Response to trastuzumab-deruxtecan in metastatic triple-negative breast cancer with both HER2 mutation and low expression. [PDF]

open access: yesEinstein (Sao Paulo)
Amarger CD   +8 more
europepmc   +1 more source

Medicina personalizada e impresión 3D de formas farmacéuticas

open access: yes, 2020
Las aplicaciones de la impresión 3D se han desarrollado notablemente en los últimos años. Desde su aparición en los años ochenta, surgieron nuevas técnicas de impresión 3D para satisfacer el interés creciente demostrado por diferentes industrias, incluida la industria farmacéutica.
openaire   +1 more source

Farmacogenómica : aspectos éticos de la medicina personalizada

open access: yes, 2010
Genetic differences between individuals (polymorphisms) condition the effects of drugs as regards toxicology (adverse effects) and pharmacotherapy. New analytical techniques allow individuals’ genetic profiles to be studied. Thus, a new discipline emerges: Pharmacogenomics, the study of all pharmacologically relevant genes as well as how they manifest ...
Gargiulo, Lilian   +1 more
openaire   +1 more source

Plan Nacional de Medicina Personalizada. [PDF]

open access: yesIBJ Clinical Pharmacology, 2019
openaire   +1 more source

Correction: Rodríguez-Bautista et al. Immune Milieu and Genomic Alterations Set the Triple-Negative Breast Cancer Immunomodulatory Subtype Tumor Behavior. <i>Cancers</i> 2021, <i>13</i>, 6256. [PDF]

open access: yesCancers (Basel)
Rodríguez-Bautista R   +14 more
europepmc   +1 more source

Editorial: “El Sida y el clamor de África” [PDF]

open access: yes, 2005
Institut Borja de Bioètica,
core  

[Technological Innovation in Total Knee Arthroplasty: Navigation, Robotics, and Customization]. [PDF]

open access: yesRev Bras Ortop (Sao Paulo)
Luzo MVM   +5 more
europepmc   +1 more source

Medicina personalizada no tratamento com estatinas

open access: yes, 2019
Uma das principais causas de morte a nível mundial é a doença cardiovascular sendo as dislipidemias um fator de risco importante para esta situação patológica. As Estatinas são um dos principais grupos de fármacos utilizados para o tratamento de dislipidemias.
openaire   +1 more source

Home - About - Disclaimer - Privacy